Sort
3,198 grants matching “mrna vaccine”
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$638,498Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Mechanisms of action, optimization and application of Bregs
$637,715James F Markmann · Massachusetts General Hospital · R01 · FY2023 · AI
The role of mTOR dysregulation in poxvirus infection
$637,016Derek Walsh · Northwestern University At Chicago · R01 · FY2025 · AI
Modified saRNA Encoded BiTEs for Lung Cancer
$635,248Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2025 · CA
Roles for virus-derived circular RNAs during RNA virus infections
$634,198Peter Sarnow · Stanford University · R56 · FY2025 · AI
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$634,145Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Unraveling Human T Follicular Helper Cell Development
$634,142Philip A Mudd · Washington University · R01 · FY2025 · AI
Mathematical modeling of Mycobacterium tuberculosis dissemination
$634,089Vitaly V. Ganusov · Texas Biomedical Research Institute · R01 · FY2024 · AI
Profiling the Leishmania-macrophage Host-pathogen Infectome
$634,000Najib M. El-Sayed · Univ Of Maryland, College Park · R01 · FY2011 · AI
Lipid nanoparticles as novel adjuvants inducing effective T follicular helper cell and humoral immune responses
$633,178Norbert Pardi · University Of Pennsylvania · R01 · FY2021 · AI
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
$632,873Elias Sayour · University Of Florida · R37 · FY2025 · CA
Human papillomavirus (HPV) infection and cervical and anal cancers
$631,270Nicolas Wentzensen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Engineered Lipid Nanoparticles and Microgel Matrix to Program Th1/Th2 Immune Response
$630,781Hai-Quan Mao · Johns Hopkins University · R01 · FY2025 · CA
Human Papillomavirus Infection in Perinatally HIV-infected Adolescents in Asia
$630,624Annette H Sohn · Foundation For Aids Research · R01 · FY2015 · HD
Induction of HIV-specific Immune Responses
$630,617Rajesh T Gandhi · Massachusetts General Hospital · R01 · FY2007 · AI
Immunomodulatory drug interventions for the prevention of host immune responses toward AAV-delivered anti-HIV antibodies
$630,197Sebastian Patrick Fuchs · University Of Miami School Of Medicine · R21 · FY2025 · OD
Animal Models Core
$629,514Barton F Haynes · Duke University · U19 · FY2020 · AI
Molecular-Targeted Radiation Therapy
$628,965C Norman Coleman · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Innovative mRNA vaccines to enhance the efficacy of T-cell transfer therapies against solid tumors
$628,499Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2024 · CA
Developing gene editing platforms for retinal degeneration.
$627,134Gaurav Sahay · Oregon State University · R01 · FY2023 · EY
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$626,795David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Lipid nanoparticles as novel adjuvants inducing effective T follicular helper cell and humoral immune responses
$626,397Norbert Pardi · University Of Pennsylvania · R01 · FY2022 · AI
Mechanism-based Targeting of the RNA Processing Machinery of SARS-CoV-2
$626,308Yogesh K Gupta · University Of Texas Hlth Science Center · R01 · FY2022 · AI
Cancer Vaccines and Modulation of Checkpoint Controls in Immunization
$626,094John Janik · Basic Sciences · Z01 · FY2007 · CA
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$625,700David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI